Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples